Xenon Pharmaceuticals XENE
NASDAQ XENE
$37.25 +0.53 (+1.44%)
At close: Sep 29, 2026 · 4:00 PM EDT

Xenon Pharmaceuticals (XENE) Common Equity (2013 - 2026)

Updated

Xenon Pharmaceuticals' Common Equity was $1.24 billion in Q2 2026, up 96.0% from $633.98 million a year earlier but down 7.1% from the prior quarter.

Analysis

Xenon Pharmaceuticals (XENE) Common Equity (2013 - 2026) Analysis & Trends

At the end of FY2025, Common Equity at Xenon Pharmaceuticals came in at $581.76 million, down 22.9% from FY2024.

  • Common Equity shows a five-year compound annual growth rate of 27.7% (FY2020 to FY2025).
  • In earlier years, Common Equity was $754.9 million in FY2024 (-18.6%), $927.92 million in FY2023 (+28.6%), $721.5 million in FY2022 (+31.2%) and $550.03 million in FY2021 (+221.0%).
  • Quarterly Common Equity has moved between $248.94 million (Q3 2021) and $1.34 billion (Q1 2026) over five years.
  • Compared with a year earlier, Common Equity was higher in three of the last eight quarters, with growth averaging 11.8%.
  • The best year-over-year quarter for Common Equity over five years was Q4 2021 (growth of 221.0%); the worst was Q3 2025 (a decline of 29.9%).
  • Per Business Quant data, XENE's Common Equity in the three quarters before Q2 2026 was $1.34 billion (Q1 2026), $581.76 million (Q4 2025) and $559.51 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 84.97 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -5.94 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 41.98 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 41.95 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 50.37 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 11.69 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 85.49 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 20.25 Bn
10 Xenon Pharmaceuticals 3.55 Bn 3.55 Bn - 1.24 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.24 Bn
Mar 31, 2026 1.34 Bn
Dec 31, 2025 581.76 Mn
Sep 30, 2025 559.51 Mn
Jun 30, 2025 633.98 Mn
Mar 31, 2025 703.96 Mn
Dec 31, 2024 754.90 Mn
Sep 30, 2024 797.81 Mn
Jun 30, 2024 844.05 Mn
Mar 31, 2024 887.70 Mn
Dec 31, 2023 927.92 Mn
Sep 30, 2023 636.59 Mn
Jun 30, 2023 646.46 Mn
Mar 31, 2023 686.94 Mn
Dec 31, 2022 721.50 Mn
Sep 30, 2022 753.12 Mn
Jun 30, 2022 785.79 Mn
Mar 31, 2022 541.85 Mn
Dec 31, 2021 550.03 Mn
Sep 30, 2021 248.94 Mn
API Access

Xenon Pharmaceuticals Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=XENE&period=max&api_key=YOUR_API_KEY